
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Mitochondrial Damage Causes Inflammation via cGAS-STING Signaling in Acute Kidney Injury
Hiroshi Maekawa, Tsuyoshi Inoue, Haruki Ouchi, et al.
Cell Reports (2019) Vol. 29, Iss. 5, pp. 1261-1273.e6
Open Access | Times Cited: 437
Hiroshi Maekawa, Tsuyoshi Inoue, Haruki Ouchi, et al.
Cell Reports (2019) Vol. 29, Iss. 5, pp. 1261-1273.e6
Open Access | Times Cited: 437
Showing 1-25 of 437 citing articles:
Mitochondrial control of inflammation
Saverio Marchi, Emma Guilbaud, Stephen W. G. Tait, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 3, pp. 159-173
Open Access | Times Cited: 560
Saverio Marchi, Emma Guilbaud, Stephen W. G. Tait, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 3, pp. 159-173
Open Access | Times Cited: 560
Mitochondrial ROS promote mitochondrial dysfunction and inflammation in ischemic acute kidney injury by disrupting TFAM-mediated mtDNA maintenance
Meng Zhao, Yizhuo Wang, Ling Li, et al.
Theranostics (2020) Vol. 11, Iss. 4, pp. 1845-1863
Open Access | Times Cited: 533
Meng Zhao, Yizhuo Wang, Ling Li, et al.
Theranostics (2020) Vol. 11, Iss. 4, pp. 1845-1863
Open Access | Times Cited: 533
Mitochondrial quality control in kidney injury and repair
Chengyuan Tang, Juan Cai, Xiao-Ming Yin, et al.
Nature Reviews Nephrology (2020) Vol. 17, Iss. 5, pp. 299-318
Open Access | Times Cited: 334
Chengyuan Tang, Juan Cai, Xiao-Ming Yin, et al.
Nature Reviews Nephrology (2020) Vol. 17, Iss. 5, pp. 299-318
Open Access | Times Cited: 334
Mitochondria in health, disease, and aging
John S. Harrington, Stefan W. Ryter, Maria Plataki, et al.
Physiological Reviews (2023) Vol. 103, Iss. 4, pp. 2349-2422
Open Access | Times Cited: 286
John S. Harrington, Stefan W. Ryter, Maria Plataki, et al.
Physiological Reviews (2023) Vol. 103, Iss. 4, pp. 2349-2422
Open Access | Times Cited: 286
Cisplatin nephrotoxicity: new insights and therapeutic implications
Chengyuan Tang, Man J. Livingston, Robert L. Safirstein, et al.
Nature Reviews Nephrology (2022) Vol. 19, Iss. 1, pp. 53-72
Closed Access | Times Cited: 270
Chengyuan Tang, Man J. Livingston, Robert L. Safirstein, et al.
Nature Reviews Nephrology (2022) Vol. 19, Iss. 1, pp. 53-72
Closed Access | Times Cited: 270
Mitochondrial dysfunction: mechanisms and advances in therapy
Zong Yao, Hao Li, Peng Liao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 239
Zong Yao, Hao Li, Peng Liao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 239
Selective packaging of mitochondrial proteins into extracellular vesicles prevents the release of mitochondrial DAMPs
Kiran Todkar, Lilia Chikhi, Véronique Desjardins, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 238
Kiran Todkar, Lilia Chikhi, Véronique Desjardins, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 238
HDAC3 inhibition ameliorates ischemia/reperfusion-induced brain injury by regulating the microglial cGAS-STING pathway
Yajin Liao, Jinbo Cheng, Xiangxi Kong, et al.
Theranostics (2020) Vol. 10, Iss. 21, pp. 9644-9662
Open Access | Times Cited: 229
Yajin Liao, Jinbo Cheng, Xiangxi Kong, et al.
Theranostics (2020) Vol. 10, Iss. 21, pp. 9644-9662
Open Access | Times Cited: 229
Trial watch: STING agonists in cancer therapy
Julie Le Naour, Laurence Zitvogel, Lorenzo Galluzzi, et al.
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 228
Julie Le Naour, Laurence Zitvogel, Lorenzo Galluzzi, et al.
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 228
Trial watch: TLR3 agonists in cancer therapy
Julie Le Naour, Lorenzo Galluzzi, Laurence Zitvogel, et al.
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 225
Julie Le Naour, Lorenzo Galluzzi, Laurence Zitvogel, et al.
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 225
Kidney physiology and susceptibility to acute kidney injury: implications for renoprotection
Holger Scholz, Felix Boivin, Kai M. Schmidt‐Ott, et al.
Nature Reviews Nephrology (2021) Vol. 17, Iss. 5, pp. 335-349
Closed Access | Times Cited: 216
Holger Scholz, Felix Boivin, Kai M. Schmidt‐Ott, et al.
Nature Reviews Nephrology (2021) Vol. 17, Iss. 5, pp. 335-349
Closed Access | Times Cited: 216
Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy
Kyle M. Garland, Taylor L. Sheehy, John T. Wilson
Chemical Reviews (2022) Vol. 122, Iss. 6, pp. 5977-6039
Open Access | Times Cited: 214
Kyle M. Garland, Taylor L. Sheehy, John T. Wilson
Chemical Reviews (2022) Vol. 122, Iss. 6, pp. 5977-6039
Open Access | Times Cited: 214
Research Advances in How the cGAS-STING Pathway Controls the Cellular Inflammatory Response
Dongshan Wan, Wei Jiang, Junwei Hao
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 213
Dongshan Wan, Wei Jiang, Junwei Hao
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 213
SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-κB
Christopher J. Neufeldt, Berati Cerikan, Mirko Cortese, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 211
Christopher J. Neufeldt, Berati Cerikan, Mirko Cortese, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 211
Cytoplasmic DNA: sources, sensing, and role in aging and disease
Karl N. Miller, Stella Victorelli, Hanna Salmonowicz, et al.
Cell (2021) Vol. 184, Iss. 22, pp. 5506-5526
Open Access | Times Cited: 191
Karl N. Miller, Stella Victorelli, Hanna Salmonowicz, et al.
Cell (2021) Vol. 184, Iss. 22, pp. 5506-5526
Open Access | Times Cited: 191
Mitochondrial function in immune cells in health and disease
Marijke M. Faas, Paul de Vos
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2020) Vol. 1866, Iss. 10, pp. 165845-165845
Open Access | Times Cited: 189
Marijke M. Faas, Paul de Vos
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2020) Vol. 1866, Iss. 10, pp. 165845-165845
Open Access | Times Cited: 189
Molecular pathways that drive diabetic kidney disease
Samer Mohandes, Tomohito Doke, Hailong Hu, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 4
Open Access | Times Cited: 182
Samer Mohandes, Tomohito Doke, Hailong Hu, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 4
Open Access | Times Cited: 182
Role of the cGAS–STING pathway in systemic and organ-specific diseases
Sladjana Skopelja‐Gardner, Jie An, Keith B. Elkon
Nature Reviews Nephrology (2022) Vol. 18, Iss. 9, pp. 558-572
Open Access | Times Cited: 177
Sladjana Skopelja‐Gardner, Jie An, Keith B. Elkon
Nature Reviews Nephrology (2022) Vol. 18, Iss. 9, pp. 558-572
Open Access | Times Cited: 177
Mitochondria dysfunction and metabolic reprogramming as drivers of idiopathic pulmonary fibrosis
Marta Bueno, Jazmín Calyeca, Mauricio Rojas, et al.
Redox Biology (2020) Vol. 33, pp. 101509-101509
Open Access | Times Cited: 164
Marta Bueno, Jazmín Calyeca, Mauricio Rojas, et al.
Redox Biology (2020) Vol. 33, pp. 101509-101509
Open Access | Times Cited: 164
Trial watch: IDO inhibitors in cancer therapy
Julie Le Naour, Lorenzo Galluzzi, Laurence Zitvogel, et al.
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 150
Julie Le Naour, Lorenzo Galluzzi, Laurence Zitvogel, et al.
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 150
Mitochondrial dysfunction and the AKI-to-CKD transition
Mingzhu Jiang, Mi Bai, Juan Lei, et al.
AJP Renal Physiology (2020) Vol. 319, Iss. 6, pp. F1105-F1116
Closed Access | Times Cited: 147
Mingzhu Jiang, Mi Bai, Juan Lei, et al.
AJP Renal Physiology (2020) Vol. 319, Iss. 6, pp. F1105-F1116
Closed Access | Times Cited: 147
Dysfunctional mitochondria as critical players in the inflammation of autoimmune diseases: Potential role in Sjögren’s syndrome
María‐José Barrera, Sergio Aguilera, Isabel Castro, et al.
Autoimmunity Reviews (2021) Vol. 20, Iss. 8, pp. 102867-102867
Closed Access | Times Cited: 141
María‐José Barrera, Sergio Aguilera, Isabel Castro, et al.
Autoimmunity Reviews (2021) Vol. 20, Iss. 8, pp. 102867-102867
Closed Access | Times Cited: 141
Oxidative Stress Is a Key Modulator in the Development of Nonalcoholic Fatty Liver Disease
Yuanqiang Ma, Gyurim Lee, Suyoung Heo, et al.
Antioxidants (2021) Vol. 11, Iss. 1, pp. 91-91
Open Access | Times Cited: 134
Yuanqiang Ma, Gyurim Lee, Suyoung Heo, et al.
Antioxidants (2021) Vol. 11, Iss. 1, pp. 91-91
Open Access | Times Cited: 134
Lipotoxicity-induced mtDNA release promotes diabetic cardiomyopathy by activating the cGAS-STING pathway in obesity-related diabetes
Xiu Mei, Kang Geng, Betty Yuen Kwan Law, et al.
Cell Biology and Toxicology (2022) Vol. 39, Iss. 1, pp. 277-299
Open Access | Times Cited: 114
Xiu Mei, Kang Geng, Betty Yuen Kwan Law, et al.
Cell Biology and Toxicology (2022) Vol. 39, Iss. 1, pp. 277-299
Open Access | Times Cited: 114
Mitochondrial DNA Release in Innate Immune Signaling
Laura Newman, Gerald S. Shadel
Annual Review of Biochemistry (2023) Vol. 92, Iss. 1, pp. 299-332
Open Access | Times Cited: 106
Laura Newman, Gerald S. Shadel
Annual Review of Biochemistry (2023) Vol. 92, Iss. 1, pp. 299-332
Open Access | Times Cited: 106